Literature DB >> 17354587

[Mumps--a reemerging infection? The current incidence of mumps in the East Bohemian region in the Czech Republic].

V Stĕpánová1, L Plísková, P Kosina, M Splino, M Förstl, R Bolehovská, J Dlhý, M Chrzová.   

Abstract

A review of mumps outbreaks among both non-vaccinated and vaccinated children and young adults in the East Bohemian region in 2003-2005 is presented. A significant increase in mumps cases was observed over this period. The clinical diagnosis was confirmed serologically by ELISA detection of IgM antibodies and/or IgG seroconversion and increased levels of IgG antibodies. A reverse transcriptase nested PCR was introduced for direct detection of mumps virus RNA from clinical specimens (nasopharyngeal secretion, saliva, CSF and serum). The isolated RNA will be stored for further analysis and mumps virus genotyping attempts, helpful in tracing the virus circulation in the East Bohemia region. Possible causes of the recent significant increase in mumps cases among the vaccinated population in the Czech Republic are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17354587

Source DB:  PubMed          Journal:  Epidemiol Mikrobiol Imunol        ISSN: 1210-7913            Impact factor:   0.444


  3 in total

1.  Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy.

Authors:  Jan Smetana; Roman Chlibek; Irena Hanovcova; Renata Sosovickova; Libuse Smetanova; Petra Polcarova; Peter Gal; Petr Dite
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

2.  In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.

Authors:  Sarah M Connaughton; Jun X Wheeler; Eva Vitková; Philip Minor; Silke Schepelmann
Journal:  Vaccine       Date:  2015-07-15       Impact factor: 3.641

3.  Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012.

Authors:  Hana Orlíková; Marek Malý; Pavla Lexová; Helena Šebestová; Radomíra Limberková; Lucie Jurzykowská; Jan Kynčl
Journal:  BMC Public Health       Date:  2016-04-01       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.